Collaborations
The CRO for CNS
Accelerating the development of new epilepsy therapeutic treatments to improve patient care is at the heart of The Epilepsy Study Consortium (TESC). Through their organizational goals of building partnerships between academia, industry, and regulatory agencies, Clinilabs is able to provide high-quality investigator sites for multicenter clinical trials. These efforts enable us to enroll adults and children with epilepsy and help bring new treatments to patients in need.
Through our partnership with TESC, Clinilabs is able to provide high-quality investigator sites for epilepsy clinical trials.
Drugs don’t work in patients who don’t take them.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
All truths are easy to understand once they are discovered; the point is to discover them.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
I am not accustomed to saying anything with certainty after only one or two observations.
I have no ideology. My ideology is health.
The reward for work well done is the opportunity to do more.
The best way to predict the future is to invent it.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
The pace of discovery is going unbelievably fast.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
One sometimes finds what one is not looking for.
There is so much more to be done; the patients are waiting.
One never notices what has been done; one can only see what remains to be done.
Good information is the best medicine.
If you think compliance is expensive, try non-compliance.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.